Haemonetics (HAE) Leases (2025 - 2026)
Haemonetics' quarterly Leases came in at $39.6 million in Q1 2026, down 16.58% year-on-year from $47.5 million in Q1 2025, and down 16.58% quarter-over-quarter from $47.5 million in Q1 2025.
Haemonetics has reported Leases for 2 years, with the latest figure at $39.6 million in Q1 2026.
- For the quarter ending Q1 2026, Leases fell 16.58% year-over-year to $39.6 million; the trailing twelve-month figure through Mar 2026 stood at $39.6 million (down 16.58% YoY), and the FY2026 full-year result was $39.6 million, down 16.58% from the prior year.
- Leases for Q1 2026 stood at $39.6 million, down from $47.5 million in the prior quarter.
- The five-year high for Leases was $47.5 million in Q1 2025, with the low at $39.6 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 547.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 99.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 73.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 396.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 155.20 Mn |
| 10 | Haemonetics | 3.18 Bn | 2.93 Bn | 198.21 Mn | 39.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 39.62 Mn |
| Mar 29, 2025 | 47.49 Mn |